Literature DB >> 27533026

Evaluation of Dyspnea Outcomes After Endoscopic Airway Surgery for Laryngotracheal Stenosis.

Idris Samad1, Lee Akst1, Selmin Karatayli-Özgürsoy1, Kristine Teets1, Marissa Simpson1, Ashwyn Sharma1, Simon R A Best1, Alexander T Hillel1.   

Abstract

Importance: Endoscopic airway surgery is a frequently used procedure in the management of laryngotracheal stenosis (LTS); however, no established outcome measures are available to assess treatment response. Objective: To assess acoustics and aerodynamic measures and voice- and dyspnea-related quality of life (QOL) in adult patients with LTS who undergo endoscopic airway surgery. Design, Setting, and Participants: This case series compared preoperative measures and postoperative outcomes among adult patients who underwent endoscopic airway surgery for LTS from September 1, 2013, to September 30, 2015, at the tertiary care Johns Hopkins Voice Center. Patients were excluded if they did not undergo balloon dilation or if they had multilevel or glottic stenosis. The Phonatory Aerodynamic System was used to quantify laryngotracheal aerodynamic changes after surgery. Final follow-up was completed 2 to 6 weeks after surgery. Main Outcomes and Measures: The voice-related QOL instrument (V-RQOL), Dyspnea Index, and Clinical Chronic Obstructive Pulmonary Disease Questionnaire were completed before and after endoscopic surgery. Consensus auditory perceptual evaluation of voice, acoustic measurements, and aerodynamic outcomes were also assessed.
Results: Fourteen patients (1 man and 13 women; mean [SD] age, 45.4 [4.3] years) were enrolled. The mean postoperative V-RQOL scores (n = 14) increased from 74.3 to 85.5 (mean of difference, 11.3; 95% CI, 2.2 to 20.3). The mean postoperative Dyspnea Index (n = 14) decreased from 26.9 to 6.6 (mean of difference, -20.3; 95% CI, -27.9 to -12.7); the mean postoperative Clinical Chronic Obstructive Pulmonary Disease Questionnaire scores (n = 9) decreased from 3.2 to 1.0 (mean of difference, -2.2; 95% CI, -3.4 to -0.9). Postoperative mean vital capacity (n = 14) increased from 2.5 to 3.1 L (mean of difference, 0.6 L; 95% CI, 0.3-1.0 L), whereas mean laryngeal resistance (n = 14) decreased from 73.9 to 46.4 cm H2O/L/s (mean of difference, -27.5 cm H2O/L/s; 95% CI, -44.8 to -10.3 cm H2O/L/s) postoperatively. Conclusions and Relevance: Patients demonstrate statistically and clinically significant improvement in dyspnea-related QOL, whereas a few patients showed a clinically significant improvement in V-RQOL. Dyspnea-related QOL outcomes should be added to airway surgeons' regular assessment of patients with LTS to measure treatment response and inform the decision to perform a second operation, whereas V-RQOL outcomes need additional prospective study with a larger sample size. The Phonatory Aerodynamic System is not an optimal method to quantify changes in laryngotracheal aerodynamics after intervention in LTS.

Entities:  

Mesh:

Year:  2016        PMID: 27533026      PMCID: PMC5516931          DOI: 10.1001/jamaoto.2016.2029

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  33 in total

1.  Measuring in situ central airway resistance in patients with laryngotracheal stenosis.

Authors:  K Wassermann; A Koch; A Warschkow; F Mathen; J Müller-Ehmsen; H E Eckel
Journal:  Laryngoscope       Date:  1999-09       Impact factor: 3.325

2.  Quality of life and voice outcomes after thyroid ala graft laryngotracheal reconstruction in young children.

Authors:  Yamilet Tirado; Neil K Chadha; Jennifer Allegro; Vito Forte; Paolo Campisi
Journal:  Otolaryngol Head Neck Surg       Date:  2011-05       Impact factor: 3.497

3.  Validation of an instrument to measure voice-related quality of life (V-RQOL).

Authors:  N D Hogikyan; G Sethuraman
Journal:  J Voice       Date:  1999-12       Impact factor: 2.009

4.  Maximum phonation time in healthy older adults.

Authors:  Jonathan Maslan; Xiaoyan Leng; Catherine Rees; David Blalock; Susan G Butler
Journal:  J Voice       Date:  2011-03-25       Impact factor: 2.009

5.  Voice quality in laryngotracheal stenosis: impact of dilation and level of stenosis.

Authors:  Alexander T Hillel; Selmin Karatayli-Ozgursoy; James R Benke; Simon Best; Paulette Pacheco-Lopez; Kristine Teets; Heather Starmer; Lee M Akst
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-12-17       Impact factor: 1.547

6.  Perceptual voice analysis of patients with subglottic stenosis.

Authors:  Sandra L Ettema; Carol Jorgensen Tolejano; Robert J Thielke; Robert J Toohill; Albert L Merati
Journal:  Otolaryngol Head Neck Surg       Date:  2006-11       Impact factor: 3.497

7.  Long-term voice outcome following partial cricotracheal resection in children for severe subglottic stenosis.

Authors:  Mercy George; Philippe Monnier
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-11-25       Impact factor: 1.675

8.  Influence of subglottic stenosis on the flow-induced vibration of a computational vocal fold model.

Authors:  Simeon L Smith; Scott L Thomson
Journal:  J Fluids Struct       Date:  2013-01-24       Impact factor: 2.917

9.  Role of subglottal shape in turbulence reduction.

Authors:  Liran Oren; Sid Khosla; Shanmugam Murugappan; Richard King; Ephraim Gutmark
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-03       Impact factor: 1.547

10.  Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire.

Authors:  J W H Kocks; M G Tuinenga; S M Uil; J W K van den Berg; E Ståhl; T van der Molen
Journal:  Respir Res       Date:  2006-04-07
View more
  2 in total

1.  Laryngotracheal Mucosal Surface Expression of Candidate Biomarkers in Idiopathic Subglottic Stenosis.

Authors:  Melissa M Liu; Kevin M Motz; Michael K Murphy; Linda X Yin; Dacheng Ding; Alexander Gelbard; Alexander T Hillel
Journal:  Laryngoscope       Date:  2020-05-05       Impact factor: 2.970

2.  Quality-of-life evaluation in patients with laryngotracheal diseases.

Authors:  Benoit Jacques Bibas; Paulo Francisco Guerreiro Cardoso; Helio Minamoto; Paulo Manoel Pêgo-Fernandes
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.